mark-20220331
truefalse000136836512/312022Q1FALSEP1Yhttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent00013683652022-01-012022-03-3100013683652022-05-12xbrli:shares00013683652022-03-31iso4217:USD00013683652021-12-31iso4217:USDxbrli:shares0001368365mark:ChinaBrandingGroupLimitedMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-01-012022-03-3100013683652021-01-012021-03-310001368365us-gaap:CommonStockMember2021-12-310001368365us-gaap:AdditionalPaidInCapitalMember2021-12-310001368365us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001368365us-gaap:RetainedEarningsMember2021-12-310001368365us-gaap:RetainedEarningsMember2022-01-012022-03-310001368365us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001368365us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001368365us-gaap:CommonStockMember2022-03-310001368365us-gaap:AdditionalPaidInCapitalMember2022-03-310001368365us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001368365us-gaap:RetainedEarningsMember2022-03-310001368365us-gaap:CommonStockMember2020-12-310001368365us-gaap:AdditionalPaidInCapitalMember2020-12-310001368365us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001368365us-gaap:RetainedEarningsMember2020-12-3100013683652020-12-310001368365us-gaap:RetainedEarningsMember2021-01-012021-03-310001368365us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001368365us-gaap:CommonStockMember2021-01-012021-03-310001368365us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001368365us-gaap:CommonStockMember2021-03-310001368365us-gaap:AdditionalPaidInCapitalMember2021-03-310001368365us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001368365us-gaap:RetainedEarningsMember2021-03-3100013683652021-03-310001368365mark:WFOEMember2022-03-31xbrli:pure0001368365currency:USD2022-03-310001368365currency:USD2021-12-310001368365currency:CNY2022-03-310001368365currency:CNY2021-12-310001368365currency:GBP2022-03-310001368365currency:GBP2021-12-310001368365currency:HKD2022-03-310001368365currency:HKD2021-12-310001368365currency:GBP2021-03-310001368365currency:CNY2021-03-310001368365currency:HKD2021-03-310001368365currency:CNYsrt:WeightedAverageMember2022-03-310001368365currency:CNYsrt:WeightedAverageMember2021-03-310001368365currency:GBPsrt:WeightedAverageMember2022-03-310001368365currency:GBPsrt:WeightedAverageMember2021-03-310001368365srt:MinimumMember2022-01-012022-03-310001368365srt:MaximumMember2022-01-012022-03-310001368365us-gaap:ProductAndServiceOtherMember2022-01-012022-03-310001368365us-gaap:ComputerSoftwareIntangibleAssetMember2022-01-012022-03-310001368365us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001368365us-gaap:EmployeeStockOptionMember2021-01-012021-03-310001368365us-gaap:WarrantMember2022-01-012022-03-310001368365us-gaap:WarrantMember2021-01-012021-03-31mark:segment0001368365mark:AIBasedProductsMember2022-01-012022-03-310001368365mark:AIBasedProductsMember2021-01-012021-03-310001368365us-gaap:ProductAndServiceOtherMember2021-01-012021-03-310001368365country:CN2022-01-012022-03-310001368365country:CN2021-01-012021-03-310001368365country:US2022-01-012022-03-310001368365country:US2021-01-012021-03-310001368365us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-03-310001368365mark:AIBasedProductsMembermark:AccountReceivableBenchmarkMemberus-gaap:ProductConcentrationRiskMember2022-01-012022-03-310001368365mark:SharecareMember2021-12-310001368365mark:SharecareMember2021-07-012021-07-010001368365mark:SharecareMember2021-07-010001368365mark:SharecareMember2022-03-310001368365mark:SharecareMember2022-01-012022-03-310001368365mark:ComputersandEquipmentMember2022-01-012022-03-310001368365mark:ComputersandEquipmentMember2022-03-310001368365mark:ComputersandEquipmentMember2021-12-310001368365us-gaap:FurnitureAndFixturesMember2022-01-012022-03-310001368365us-gaap:FurnitureAndFixturesMember2022-03-310001368365us-gaap:FurnitureAndFixturesMember2021-12-310001368365us-gaap:ComputerSoftwareIntangibleAssetMember2022-03-310001368365us-gaap:ComputerSoftwareIntangibleAssetMember2021-12-310001368365us-gaap:LeaseholdImprovementsMember2022-01-012022-03-310001368365us-gaap:LeaseholdImprovementsMember2022-03-310001368365us-gaap:LeaseholdImprovementsMember2021-12-310001368365mark:SoftwareDevelopmentInProgressMember2022-03-310001368365mark:SoftwareDevelopmentInProgressMember2021-12-310001368365us-gaap:NotesPayableOtherPayablesMembermark:MudrickLoanAgreementsMember2022-03-310001368365us-gaap:NotesPayableOtherPayablesMembermark:MudrickLoanAgreementsMember2021-12-310001368365us-gaap:LoansPayableMembermark:MudrickLoanAgreementsMember2021-12-030001368365us-gaap:LoansPayableMembermark:MudrickLoanAgreementsMember2022-01-012022-03-3100013683652021-09-2700013683652021-09-272021-09-270001368365us-gaap:WarrantMember2021-12-310001368365us-gaap:WarrantMember2021-01-012021-03-310001368365us-gaap:WarrantMember2022-01-012022-03-310001368365us-gaap:WarrantMember2022-03-310001368365us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001368365us-gaap:EmployeeStockOptionMember2021-12-310001368365us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001368365us-gaap:EmployeeStockOptionMember2022-03-310001368365mark:ChinaCashBonusAwardsMember2021-12-310001368365mark:ChinaCashBonusAwardsMember2021-01-012021-12-310001368365mark:ChinaCashBonusAwardsMember2022-01-012022-03-310001368365mark:ChinaCashBonusAwardsMember2022-03-310001368365mark:ChinaCashBonusAwardsMember2020-12-310001368365mark:ChinaCashBonusAwardsMember2020-07-272020-07-2700013683652021-07-0800013683652020-07-272020-07-270001368365us-gaap:EmployeeStockOptionMember2021-07-082021-07-080001368365us-gaap:EmployeeStockOptionMember2021-01-012021-03-310001368365mark:ChinaCashBonusAwardsMember2021-01-012021-03-310001368365mark:ChinaBrandingGroupLimitedMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2020-12-310001368365mark:ChinaBrandingGroupLimitedMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2020-01-012020-03-310001368365us-gaap:ConsolidatedEntityExcludingVieMember2022-03-310001368365srt:ConsolidationEliminationsMember2022-03-310001368365us-gaap:ConsolidatedEntityExcludingVieMember2022-01-012022-03-310001368365us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-01-012022-03-310001368365srt:ConsolidationEliminationsMember2022-01-012022-03-310001368365us-gaap:ConsolidatedEntityExcludingVieMember2021-12-310001368365us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-12-310001368365srt:ConsolidationEliminationsMember2021-12-310001368365us-gaap:SubsequentEventMembermark:MudrickLendersMember2022-04-042022-04-04

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended March 31, 2022

https://cdn.kscope.io/fa8cc8a9b99f4ddd55385c3a39427516-mark-20220331_g1.jpg
Commission File Number 001-33720
Remark Holdings, Inc.
Delaware33-1135689
State of IncorporationIRS Employer Identification Number

800 S. Commerce St.
Las Vegas, NV 89106

Address, including zip code, of principal executive offices

702-701-9514

Registrant’s telephone number, including area code


Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $0.001 par value per shareMARKThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

As of May 12, 2022, a total of 105,157,769 shares of our common stock were outstanding.



TABLE OF CONTENTS

PART I
Item 1.
Item 2.
Item 3.
Item 4.
PART II
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.



SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

The matters discussed in this Quarterly Report on Form 10-Q (this “Form 10-Q”) include “forward-looking statements” about the plans, strategies, objectives, goals or expectations of Remark Holdings, Inc. and subsidiaries (“Remark”, “we”, “us”, “our”). You will find forward-looking statements principally in the sections entitled Risk Factors and Management’s Discussion and Analysis of Financial Condition and Results of Operations. Such forward-looking statements are identifiable by words or phrases indicating that Remark or management “expects,” “anticipates,” “plans,” “believes,” or “estimates,” or that a particular occurrence or event “will,” “may,” “could,” “should,” or “will likely” result, occur or be pursued or “continue” in the future, that the “outlook” or “trend” is toward a particular result or occurrence, that a development is an “opportunity,” “priority,” “strategy,” “focus,” that we are “positioned” for a particular result, or similarly-stated expectations. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this report or such other report, release, presentation, or statement.

In addition to other risks and uncertainties described in connection with the forward-looking statements contained in this report and other periodic reports filed with the Securities and Exchange Commission (“SEC”), there are many important factors that could cause actual results to differ materially. Such risks and uncertainties include general business conditions, changes in overall economic conditions, our ability to integrate acquired assets, the impact of competition and other factors which are often beyond our control.

This should not be construed as a complete list of all of the economic, competitive, governmental, technological and other factors that could adversely affect our expected consolidated financial position, results of operations or liquidity. Additional risks and uncertainties not currently known to us or that we currently believe are immaterial also may impair our business, operations, liquidity, financial condition and prospects. We undertake no obligation to update or revise our forward-looking statements to reflect developments that occur or information that we obtain after the date of this report.




PART I FINANCIAL INFORMATION
ITEM 1.    FINANCIAL STATEMENTS

REMARK HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(dollars in thousands, except share and per share amounts)
March 31, 2022December 31, 2021
(Unaudited)
Assets
Cash$2,691 $14,187 
Trade accounts receivable, net11,293 10,267 
Inventory, net1,492 1,346 
Investment in marketable securities21,444 42,349 
Prepaid expense and other current assets8,273 6,363 
Total current assets45,193 74,512 
Property and equipment, net1,274 357 
Operating lease assets246 194 
Other long-term assets403 440 
Total assets$47,116 $75,503 
Liabilities
Accounts payable$10,099 $10,094 
Accrued expense and other current liabilities5,201 5,963 
Contract liability432 576 
Notes payable, net of unamortized discount and debt issuance cost of $1,095 and $2,189 at March 31, 2022 and December 31, 2021, respectively
25,208 27,811 
Total current liabilities40,940 44,444 
Operating lease liabilities, long-term55 25 
Total liabilities40,995 44,469 
Commitments and contingencies
Stockholders’ Equity
Preferred stock, $0.001 par value; 1,000,000 shares authorized; zero issued
  
Common stock, $0.001 par value; 175,000,000 shares authorized; 105,157,769 shares issued and outstanding at each of March 31, 2022 and December 31, 2021
105 105 
Additional paid-in-capital364,753 364,239 
Accumulated other comprehensive income(268)(270)
Accumulated deficit(358,469)(333,040)
Total stockholders’ equity6,121 31,034 
Total liabilities and stockholders’ equity$47,116 $75,503 

See Notes to Unaudited Condensed Consolidated Financial Statements

REMARK HOLDINGS, INC. AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss
(dollars in thousands, except per share amounts)
Three Months Ended March 31,
20222021
Revenue, including $2.2 million from China Business Partner (See Note 13)
$4,667 $4,406 
Cost and expense
Cost of revenue (excluding depreciation and amortization)4,270 2,752 
Sales and marketing148 1,001 
Technology and development455 1,550 
General and administrative3,939 2,697 
Depreciation and amortization41 66 
Total cost and expense8,853 8,066 
Operating loss(4,186)(3,660)
Other income (expense)
Interest expense(2,186)(235)
Change in fair value of warrant liability (1,610)
Loss on investment(19,056) 
Other gain (loss), net(1)44 
Total other expense, net(21,243)(1,801)
Net loss$(25,429)$(5,461)
Other comprehensive income
Foreign currency translation adjustments2 42 
Comprehensive loss$(25,427)$(5,419)
Weighted-average shares outstanding, basic and diluted105,157,769 99,758,589 
Net loss per share, basic and diluted$(0.24)$(0.05)

See Notes to Unaudited Condensed Consolidated Financial Statements

REMARK HOLDINGS, INC. AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Stockholders’ Equity (Deficit)
(in thousands, except number of shares)
Three Months Ended March 31, 2022
Common Stock SharesCommon Stock Par ValueAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Accumulated DeficitTotal
Balance at December 31, 2021
105,157,769 $105 $364,239 $(270)$(333,040)$31,034 
Net loss— — — — (25,429)(25,429)
Share-based compensation— — 514 — — 514 
Foreign currency translation— — — 2 — 2 
Balance at March 31, 2022
105,157,769 $105 $364,753 $(268)$(358,469)$6,121 
Three Months Ended March 31, 2021
Common Stock SharesCommon Stock Par ValueAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Accumulated DeficitTotal
Balance at December 31, 2020
99,505,041 $100 $351,546 $(226)$(360,512)$(9,092)
Net loss— — — — (5,461)(5,461)
Share-based compensation— — 20 — — 20 
Equity instrument exercises411,900 — 821 — — 821 
Foreign currency translation— — — 42 — 42 
Balance at March 31, 2021
99,916,941 $100 $352,387 $(184)$(365,973)$(13,670)

See Notes to Unaudited Condensed Consolidated Financial Statements

REMARK HOLDINGS, INC. AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Cash Flows
(dollars in thousands)
Three Months Ended March 31,
20222021
Cash flows from operating activities:
Net loss
$(25,429)$(5,461)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liability
 1,610 
Depreciation, amortization and impairments
41 66 
Share-based compensation
429 267 
Amortization of debt issuance costs and discount
1,095 63 
Loss on investment in marketable securities
19,056  
Other
43 37 
Changes in operating assets and liabilities:
Accounts receivable
(1,052)(2,938)
Inventory(146)(795)
Prepaid expense and other assets
(1,895)566 
Operating lease assets
(52)90 
Accounts payable, accrued expense and other liabilities
(666)968 
Contract liability
(142)48 
Operating lease liabilities
30 (49)
Net cash used in operating activities
(8,688)(5,528)
Cash flows from investing activities:
Proceeds from sale of investment1,849  
Purchases of property, equipment and software
(10)(11)
Payment of amounts capitalized to software in progress(949) 
Net cash provided by (used in) investing activities
890 (11)
Cash flows from financing activities:
Proceeds from issuance of common stock, net
 821 
Proceeds from debt issuance
 4,770 
Repayments of debt
(3,698) 
Net cash provided by (used in) financing activities
(3,698)5,591 
Net change in cash
(11,496)52 
Cash:
Beginning of period
14,187 854 
End of period
$2,691 $906 
Supplemental cash flow information:
Cash paid for interest
$1,092 $ 
Supplemental schedule of non-cash investing and financing activities:
Accrual of debt issuance cost$ $285 
Change in liability for China Cash Bonuses (Note 12)
$84 $248 

See Notes to Unaudited Condensed Consolidated Financial Statements

REMARK HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 1. ORGANIZATION AND BUSINESS

Organization and Business

Remark Holdings, Inc. and its subsidiaries (“Remark”, “we”, “us”, or “our”), and the variable-interest entities (“VIEs”) that Remark consolidates, constitute a diversified global technology business with leading artificial intelligence (“AI”) and data-analytics, as well as a portfolio of digital media properties. The common stock of Remark Holdings, Inc. is listed on the Nasdaq Capital Market under the ticker symbol MARK.

We and the VIEs primarily sell AI-based products and services. We recognize revenue from sales in the U.S., while the VIEs generate substantially all of their revenue from China.


Corporate Structure

We are a holding company incorporated in Delaware and not a Chinese operating company. As a holding company, we conduct a significant part of our operations through our subsidiaries and through contractual arrangements with the VIEs based in China. We use the VIE structure to address challenges resulting from laws, policies and practices that may disfavor foreign-owned entities that operate within industries deemed sensitive by the Chinese government. We own 100% of the equity of a wholly foreign owned enterprise (“WFOE”), which has entered into contractual arrangements with the VIEs, which are owned by members of our management team in China and/or by third parties.

We fund the registered capital and operating expenses of the VIEs on behalf of the shareholders of the VIEs by making advances to the VIEs. We believe that we are the primary beneficiary of the VIEs because the contractual arrangements governing the relationship between the VIEs and our WFOE, which include an exclusive call option agreement, exclusive business cooperation agreement, a proxy agreement and an equity pledge agreement, enable us to (i) exercise effective control over the VIEs, (ii) receive substantially all of the economic benefits of the VIEs, and (iii) have an exclusive call option to purchase, at any time, all or part of the equity interests in and/or assets of the VIEs to the extent permitted by Chinese laws. Because these contractual arrangements with the VIEs provide us with the power to direct the activities of the VIEs, for accounting purposes we are the primary beneficiary of the VIEs and we have consolidated the financial results of the VIEs in our consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”).

The agreements governing the VIE contractual arrangements have not been tested in a court of law. However, an article published in China Business Law Journal indicated that a China International Economic and Trade Arbitration Commission (“CIETAC”) Shanghai tribunal ruled in 2010 and 2011 in two related cases involving the contractual arrangement of an online game operating company that the contractual arrangement was void on the grounds that such arrangement violated the mandatory administrative regulations prohibiting foreign investors from investing in the online game operation business and constituted “concealing illegal intentions with a lawful form.” According to publicly available information, while the agreements entered into by the parties in the aforementioned CIETAC cases are typical VIE agreements, the PRC domestic company involved in such cases was mainly engaged in online game operation. Although the PRC foreign investment regime restricts or prohibits foreign investment in certain industries, online game operation is one of few industries where there are rules specifically prohibiting foreign investors from controlling and participating in the business indirectly through contractual or technical support arrangements. Though the agreements in the CIETAC cases are similar to our contractual arrangements with the VIEs, we and the VIEs do not operate in the online game operation industry and, to our knowledge, the business conducted by the VIEs is not prohibited from investment from foreign investors in China. We also note that the rulings in the CIETAC cases are not binding on Chinese courts or other arbitration tribunals.

The following diagram illustrates our corporate structure, including our significant subsidiaries, and the relationship between our WFOE and the VIEs as of the date of this Form 10-Q. The diagram omits certain entities which are immaterial to our results of operations and financial condition. Equity interests depicted in this diagram are 100% owned. The relationships between each of Chengdu Remark Technology Co., Ltd., Hangzhou Shufeng Technology Co., Ltd., Remark Data Technology Co., Ltd. and Bonet (Beijing) Technology LLC, which constitute the VIEs, on the one hand, and KanKan Technology (Shanghai) Co., Ltd., our WFOE, on the other hand, as illustrated in the following diagram are governed by contractual arrangements and do not constitute equity ownership.




https://cdn.kscope.io/fa8cc8a9b99f4ddd55385c3a39427516-mark-20220331_g2.jpg


Because we do not directly hold equity interests in the VIEs, we are subject to risks and uncertainties of the interpretations and applications of Chinese laws and regulations, including but not limited to, the validity and enforcement of the contractual arrangements among the WFOE, the VIEs and the shareholders of the VIEs. We are also subject to the risks and uncertainties about any future actions of the Chinese government in this regard that could disallow the VIE structure, which would likely result in a material change in our operations and may cause the value of our common stock to depreciate significantly or become worthless.



The contractual arrangements may not be as effective as direct ownership in providing operational control and we face contractual exposure in such arrangements. For instance, the VIEs and their shareholders could breach their contractual arrangements with us by, among other things, failing to conduct their operations in an acceptable manner or taking other actions that are detrimental to our interests. The shareholders of the VIEs may not act in the best interests of our Company or may not perform their obligations under these contracts. Such risks exist throughout the period in which we intend to operate certain portions of our business through the contractual arrangements with the VIEs. In the event that the VIEs or their shareholders fail to perform their respective obligations under the contractual arrangements, we may have to incur substantial costs and expend additional resources to enforce such arrangements. In addition, even if legal actions are taken to enforce such arrangements, there is uncertainty as to whether Chinese courts would recognize or enforce judgments of U.S. courts against us or such persons predicated upon the civil liability provisions of the securities laws of the United States or any state.


Risks of Doing Business in China

We are subject to certain legal and operational risks associated with having a significant portion of our operations in China. Chinese laws and regulations governing our current business operations, including the enforcement of such laws and regulations, are sometimes vague and uncertain and can change quickly with little advance notice. The Chinese government may intervene or influence our operations and the operations of the VIEs at any time and may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers, which could result in a material change in our operations and/or the value of our securities. In addition, any actions by the Chinese government to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers could significant limit or completely hinder our ability to offer or continue to offer our securities to investors and cause the value of such securities to significantly decline or become worthless. Recently, the Chinese government adopted a series of regulatory actions and issued statements to regulate business operations in China, including those related to the use of variable interest entities, data security and anti-monopoly concerns. As of the date of this Form 10-Q, neither we nor the VIEs have been involved in any investigations on cybersecurity review initiated by any Chinese regulatory authority, nor has any of them received any inquiry, notice or sanction. As of the date of this Form 10-Q, no relevant laws or regulations in China explicitly require us to seek approval from the China Securities Regulatory Commission (the “CSRC”) for any securities listing. As of the date of this Form 10-Q, neither we nor the VIEs have received any inquiry, notice, warning or sanctions regarding our planned overseas listing from the CSRC or any other Chinese governmental authorities relating to securities listings. However, since these statements and regulatory actions are newly published, official guidance and related implementation rules have not been issued. It is highly uncertain what potential impact such modified or new laws and regulations will have on our ability to conduct our business, accept investments or list or maintain a listing on a U.S. or foreign exchange.

As of the date of this Form 10-Q, we and the VIEs are not required to seek permissions from the CSRC, the Cyberspace Administration of China (the “CAC”), or any other entity that is required to approve of the operations of the VIEs. Nevertheless, Chinese regulatory authorities may in the future promulgate laws, regulations or implement rules that require us, our subsidiaries or the VIEs to obtain permissions from such regulatory authorities to approve the operations of the VIEs or any securities listing.


Transfer of Cash or Assets

Dividend Distributions

As of the date of this Form 10-Q, none of our subsidiaries or any of the consolidated VIEs have made any dividends or distributions to us.

We have never declared or paid dividends or distributions on our common equity. We currently intend to retain all available funds and any future consolidated earnings to fund our operations and continue the development and growth of our business; therefore, we do not anticipate paying any cash dividends.

Under Delaware law, a Delaware corporation’s ability to pay cash dividends on its capital stock requires the corporation to have either net profits or positive net assets (total assets less total liabilities) over its capital. If we determine to pay dividends on any of our common stock in the future, as a holding company, we may rely on dividends and other distributions on equity from our WFOE for cash requirements, including the funds necessary to pay dividends and other cash contributions to our stockholders.



Our WFOE’s ability to distribute dividends is based upon its distributable earnings. Current Chinese regulations permit our WFOE to pay dividends to their shareholders only out of its registered capital amount, if any, as determined in accordance with Chinese accounting standards and regulations, and then only after meeting the statutory reserve equal to 50% of registered capital. If our WFOE incurs debt in the future, the instruments governing the debt may restrict its ability to pay dividends or make other payments to us. Any limitation on the ability of our WFOE to distribute dividends or other payments to us could materially and adversely limit our ability to grow, make investments or acquisitions that could be beneficial to our businesses, pay dividends or otherwise fund and conduct our business. In addition, any cash dividends or distributions of assets by our WFOE to its stockholder are subject to a Chinese withholding tax of as much as 10%.

The Chinese government also imposes controls on the conversion of RMB into foreign currencies and the remittance of currencies out of China. Therefore, we may experience difficulties in completing the administrative procedures necessary to obtain and remit foreign currency for the payment of dividends from our profits, if any. If we are unable to receive all of the revenues from our operations through the current VIE contractual arrangements, we may be unable to pay dividends on our common stock.

For us to pay dividends to our stockholders, we will rely on payments made from the VIEs to our WFOE in accordance with the VIE contractual arrangements, and the distribution of payments from the WFOE to the Delaware holding company as dividends. Certain payments from the VIEs to the WFOE pursuant to the VIE contractual arrangements are subject to Chinese taxes, including a 6% VAT and 25% enterprise income tax.


Our Company’s Ability to Settle Amounts Owed under the VIE Contractual Arrangements

Under the VIE contractual arrangements, the VIEs are obligated to make payments to our WFOE, in cash or in kind, at the WFOE’s request. We will be able to settle amounts owed under the VIE contractual arrangements through dividends paid by our WFOE to our Company. Such ability may be restricted or limited as follows:

First, any payments from the VIEs to our WFOE are subject to Chinese taxes, including a 6% VAT and 25% enterprise income tax.

Second, current Chinese regulations permit our WFOE to pay dividends to their shareholders only out of its registered capital amount, if any, as determined in accordance with Chinese accounting standards and regulations, and then only after meeting the statutory reserve equal to 50% of registered capital. In addition, if our WFOE incurs debt in the future, the instruments governing the debt may restrict its ability to pay dividends or make other payments to the Delaware holding company.

Third, the Chinese government also imposes controls on the conversion of RMB into foreign currencies and the remittance of currencies out of China. Therefore, we may experience difficulties in completing the administrative procedures necessary to obtain and remit foreign currency for the payment of dividends from profits, if any.


COVID-19

Our consolidated financial statements for the three months ended March 31, 2022 were impacted by the effects of the COVID-19 pandemic. The response to the COVID-19 pandemic will likely continue to adversely affect our business and financial results, as could economic and geopolitical conditions in some international regions, and we do not yet know what will be the ultimate effects on our business. The COVID-19 pandemic caused a broad shift towards remote working arrangements for many businesses worldwide and injected uncertainty and delay into decision-making processes for such businesses. Varying degrees of preventative measures are still in place in China and other parts of the world, including city-wide lockdowns, travel restrictions, closures of non-essential businesses and other quarantine measures. In particular, the preventative measures in China as a result of the Chinese government’s “Zero-COVID” policy have significantly limited the operational capabilities of the VIEs. Many cities across large swaths of China have recently been fully or partially locked down for weeks or even months, including economically significant regions such as Shanghai. Such lockdowns have had a material adverse impact on our business and we expect them to continue to have a material adverse impact on our business at least through the second quarter of 2022.



The full extent of the impact of the pandemic on our business and financial results will depend largely on future developments, including resurgences and further spread of existing or new COVID-19 variants, the duration of any remaining preventative measures implemented by domestic and foreign governments, the impact on capital and financial markets and the related impact on the financial circumstances of our customers, all of which are highly uncertain and cannot be predicted. The pandemic-related situation continues to change rapidly, and additional impacts of which we are not currently aware may arise. We are closely monitoring worldwide developments and are continually assessing the potential impact on our business.

 
Going Concern
 
During the three months ended March 31, 2022, and in each fiscal year since our inception, we have incurred operating losses which have resulted in an accumulated deficit of $358.5 million within stockholders’ equity as of March 31, 2022. Additionally, our operations have historically used more cash than they have provided. Net cash used in operating activities was $8.7 million during the three months ended March 31, 2022. As of March 31, 2022, our cash balance was $2.7 million.

Our history of recurring operating losses, working capital deficiencies and negative cash flows from operating activities give rise to, and management has concluded that there is, substantial doubt regarding our ability to continue as a going concern. Our independent registered public accounting firm, in its report on our consolidated financial statements for the year ended December 31, 2021, has also expressed substantial doubt about our ability to continue as a going concern. Our consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

We intend to fund our future operations and meet our financial obligations through revenue growth from our AI offerings, as well as through sales of our thermal-imaging products. We cannot, however, provide assurance that revenue, income and cash flows generated from our businesses will be sufficient to sustain our operations in the twelve months following the filing of this Form 10-Q. As a result, we are actively evaluating strategic alternatives including debt and equity financings and potential sales of investment assets.

Conditions in the debt and equity markets, as well as the volatility of investor sentiment regarding macroeconomic and microeconomic conditions (in particular, as a result of the COVID-19 pandemic, global supply chain disruptions, inflation and other cost increases, and the geopolitical conflict in Ukraine), will play primary roles in determining whether we can successfully obtain additional capital. We cannot be certain that we will be successful at raising additional capital.

A variety of factors, many of which are outside of our control, affect our cash flow; those factors include the effects of the COVID-19 pandemic, regulatory issues, competition, financial markets and other general business conditions. Based on financial projections, we believe that we will be able to meet our ongoing requirements for at least the next 12 months with existing cash and based on the probable success of one or more of the following plans:

develop and grow new product line(s)

monetize existing assets

obtain additional capital through debt and/or equity issuances.

However, projections are inherently uncertain and the success of our plans is largely outside of our control. As a result, there is substantial doubt regarding our ability to continue as a going concern, and we may fully utilize our cash resources prior to May 16, 2023.


NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

We prepared the accompanying unaudited Condensed Consolidated Balance Sheet as of March 31, 2022, with the audited Consolidated Balance Sheet amounts as of December 31, 2021 presented for comparative purposes, and the related unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss, the Condensed Consolidated Statements of Cash Flows and the Condensed Consolidated Statements of Stockholders’ Deficit in accordance with the instructions for Form 10-Q. In compliance with those instructions, we have omitted certain information and footnote disclosures normally included in


annual consolidated financial statements prepared in accordance with U.S. GAAP, though management believes the disclosures made herein are sufficient to ensure that the information presented is not misleading.

Our results of operations and our cash flows as of the end of the interim periods reported herein do not necessarily indicate the results we may experience for the remainder of the year or for any other future period.

Management believes that we have included all adjustments (including those of a normal, recurring nature) considered necessary to fairly present our unaudited Condensed Consolidated Balance Sheet and our unaudited Condensed Consolidated Statement of Stockholders’ Deficit, each as of March 31, 2022, as well as our unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss and Condensed Consolidated Statements of Cash Flows for all periods presented. You should read our unaudited condensed consolidated interim financial statements and footnotes in conjunction with our consolidated financial statements and footnotes included within the Annual Report on Form 10-K for the year ended December 31, 2021 (the “2021 Form 10-K”).


Consolidation

We include all of our subsidiaries and the VIEs in our condensed consolidated financial statements, eliminating all significant intercompany balances and transactions during consolidation.
 

Use of Estimates
 
We prepare our consolidated financial statements in conformity with GAAP. While preparing our financial statements, we make estimates and assumptions that affect amounts reported and disclosed in the consolidated financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, share-based compensation, deferred income taxes, and inventory reserve, among other items.

The impact of the COVID-19 pandemic continues to unfold. As a result, many of our estimates and assumptions required increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, our estimates may change materially in future periods.


Cash

Our cash consists of funds held in bank accounts.

We maintain cash balances in United States dollars (“USD”) and British pounds (“GBP”), while the VIEs maintain cash balances in USD, Chinese Renminbi (“RMB”) and Hong Kong dollars (“HKD”). The following table, reported in USD, disaggregates our cash balances by currency denomination (in thousands):
March 31, 2022December 31, 2021
Cash denominated in:
USD$2,161 $13,278 
RMB103 259 
GBP422 644 
HKD5 6 
Total cash$2,691 $14,187 


We maintain substantially all of our USD-denominated cash at a U.S. financial institution where the balances are insured by the Federal Deposit Insurance Corporation up to $250,000. At times, however, our cash balances may exceed the FDIC-


insured limit. As of March 31, 2022, we do not believe we have any significant concentrations of credit risk, although approximately $1.8 million of our USD-denominated cash balance exceeded the FDIC-insured limit. Cash held by our non-U.S. subsidiaries and the VIEs is subject to foreign currency fluctuations against the USD, although such risk is somewhat mitigated because we transfer U.S. funds to China to fund local operations. If, however, the USD is devalued significantly against the RMB, our cost to further develop our business in China could exceed original estimates.


Marketable Securities

Investment in marketable securities consists of marketable equity securities. We classify marketable securities as current or noncurrent based on the nature of the securities and their availability for use in current operations. Marketable securities are stated at fair value with all realized and unrealized gains and losses recognized in our Statement of Operations. The realized and unrealized gains and losses on marketable securities are determined using the specific identification method and quoted prices in an active market.


Fair Value of Financial Instruments

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants (an exit price). When reporting the fair values of our financial instruments, we prioritize those fair value measurements into one of three levels based on the nature of the inputs, as follows:

Level 1:    Valuations based on quoted prices in active markets for identical assets and liabilities;

Level 2:    Valuations based on observable inputs that do not meet the criteria for Level 1, including quoted prices in inactive markets and observable market data for similar, but not identical instruments; and

Level 3:    Valuations based on unobservable inputs, which are based upon the best available information when external market data is limited or unavailable.

The fair value hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. For some products or in certain market conditions, observable inputs may not be available.

We believe the reported carrying amounts for cash, marketable securities, receivables, prepaids and other current assets, accounts payable, accrued expense and other current liabilities, and short-term debt approximate their fair values because of the short-term nature of these financial instruments.


Foreign Currency Translation

We report all currency amounts in USD. The VIEs, however, maintain their books and records in their functional currency, which is RMB.

In general, when consolidating our subsidiaries or the VIEs with non-USD functional currencies, we translate the amounts of assets and liabilities into USD using the exchange rate on the balance sheet date, and the amounts of revenue and expense are translated at the average exchange rate prevailing during the period. The gains and losses resulting from translation of financial statement amounts into USD are recorded as a separate component of accumulated other comprehensive loss within stockholders’ deficit.



We used the exchange rates in the following table to translate amounts denominated in non-USD currencies as of and for the periods noted:
20222021
Exchange rates at March 31st:
GBP:USD1.313  
RMB:USD0.158 0.152 
HKD:USD0.128 0.129 
Average exchange rate during the three months ended March 31st:
RMB:USD0.158 0.154 
GBP:USD1.317  


Revenue Recognition

AI-Based Products

We and the VIEs generate revenue by developing AI-based products, including fully-integrated AI solutions which combine our proprietary technology with third-party hardware and software products to meet end-user specifications. Under one type of contract for our AI-based products, we provide a single, continuous service to clients who control the assets as we create them. Accordingly, we recognize the revenue over the period of time during which we provide the service. Under another type of contract, we have performance obligations to provide fully-integrated AI solutions to our customer and we recognize revenue at the point in time when each performance obligation is completed and delivered to, tested by and accepted by our customer.

We recognize revenue when we transfer control of the promised goods or services to our customers, and we recognize an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. If there is uncertainty related to the timing of collections from our customer, which may be the case if our customer is not the ultimate end user of our goods, we consider this to be uncertainty of the customer’s ability and intention to pay us when consideration is due. Accordingly, we recognize revenue only when we have transferred control of the goods or services and collectability of consideration from the customer is probable.

When customers pay us prior to when we satisfy our obligation to transfer control of promised goods or services, we record the amount that reflects the consideration to which we expect to be entitled as a contract liability until such time as we satisfy our performance obligation.

For our contracts with customers, we generally extend short-term credit policies to our customers, typically up to one year for large-scale projects.

We record the incremental costs of obtaining contracts as an expense when incurred.

We and the VIEs offer extended warranties on our products for periods of one to three years. Revenue from these extended warranties is recognized on a straight-line basis over the warranty contract term.

Other

We generate revenue from other sources, such as from advertising and marketing services or e-commerce activity in which we sell goods to our customers. We recognize the revenue from these contracts at the point in time when we transfer control of the good sold to the customer or when we deliver the promised promotional materials or media content. Substantially all of our contracts with customers that generate Other revenue are completed within one year or less.




Inventory

We and the VIEs use the first-in first-out method to determine the cost of our inventory, then we report inventory at the lower of cost or net realizable value. We regularly review our inventory quantities on hand and record a provision for excess and obsolete inventory based primarily on our estimated sales forecasts. At March 31, 2022 and December 31, 2021, reserve for inventory was $0.9 million and $1.0 million, respectively.


Internal Use Software

We acquire or develop applications and other software that help us meet our internal needs with respect to operating our business. For such projects, planning cost and other costs related to the preliminary project stage, as well as costs incurred for post-implementation activities, are expensed as incurred. We capitalize costs incurred during the application development phase only when we believe it is probable the development will result in new or additional functionality. The types of costs capitalized during the application development phase include fees incurred with third parties for consulting, programming and other development activities performed to complete the software. We amortize our internal use software on a straight-line basis over an estimated useful life of three years. If we identify any internal use software to be abandoned, the cost less the accumulated amortization, if any, is recorded as amortization expense. Once we have fully amortized internal use software costs that we capitalized, we remove such amounts from their respective accounts.


Net Income (Loss) per Share

We calculate basic net income (loss) per share using the weighted-average number of common stock shares outstanding during the period. For the calculation of diluted net income (loss) per share, we give effect to all the shares of common stock that were outstanding during the period plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation when their effect is anti-dilutive. Dilutive potential shares of common stock consist of incremental shares of common stock issuable upon exercise of stock options and warrants.

For the three months ended March 31, 2022 and 2021, there were no reconciling items related to either the numerator or denominator of the loss per share calculation, as their effect would have been anti-dilutive.

Securities which may have affected the calculation of diluted earnings per share for the years ended March 31, 2022 and 2021 if their effect had been dilutive include 14,330,565 and 9,528,965 outstanding stock options, respectively, and 10,114,408 and 40,000 outstanding stock warrants, respectively.


Segments

Existing GAAP, which establishes a management approach to segment reporting, defines operating segments as components of an entity about which separate, discrete financial information is available for evaluation by the chief operating decision maker. We have identified our Chief Executive Officer as our chief operating decision maker, who reviews operating results to make decisions about allocating resources and assessing performance based upon only one operating segment.


Recently Issued Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06 (“ASU 2020-06”), Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models will result in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception


from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The ASU also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. With regard to our financial reporting, ASU 2020-06 will be effective January 1, 2024, and early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. We are currently evaluating what effect(s) the adoption of ASU 2020-06 may have on our consolidated financial statements, but we do not believe the impact of the ASU will be material to our financial position, results of operations and cash flows. The effect will largely depend on the composition and terms of the financial instruments at the time of adoption.

In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments (Topic 326). The ASU requires entities to use a forward-looking approach based on current expected credit losses to estimate credit losses on certain types of financial instruments, including trade receivables, which may result in the earlier recognition of allowances for losses. With regard to our financial reporting, ASU 2016-13 will be effective beginning January 1, 2023, and early adoption is permitted. We do not believe the impact of the ASU will be material to our financial position, results of operations and cash flows.

We have reviewed all accounting pronouncements recently issued by the FASB and the SEC. The authoritative pronouncements that we have already adopted did not have a material effect on our financial condition, results of operations, cash flows or reporting thereof, and except as otherwise noted above, we do not believe that any of the authoritative pronouncements that we have not yet adopted will have a material effect upon our financial condition, results of operations, cash flows or reporting thereof.


NOTE 3. REVENUE

We and the VIEs primarily sell AI-based products and services. In the U.S., that includes our Remark AI Thermal Kits and rPads, while the VIEs sell various customized products in China based upon computer vision and other technologies.

We do not include disclosures related to remaining performance obligations because substantially all our contracts with customers have an original expected duration of one year or less or, with regard to our stand-ready obligations, the amounts involved are not material.


Disaggregation of Revenue

The following table presents a disaggregation of our revenue by category of products and services (in thousands):
Three Months Ended March 31,
20222021
AI-based products and services, including $2.2 million from China Business Partner (See Note 13)
$4,546 $4,020 
Other121 386 
Revenue$4,667 $4,406 


The following table presents a disaggregation of our revenue by country (in thousands):
Three Months Ended March 31,
20222021
China$4,554 $4,020 
United States113 386 
Revenue$4,667 $4,406 




The VIEs generated substantially all of the revenue from China noted in the table above, though one of our subsidiaries generated amounts of revenue from China that were not material in each period.


Significant Judgments

When accounting for revenue we make certain judgments, such as whether we act as a principal or as an agent in transactions or whether our contracts with customers fall within the scope of current GAAP regarding revenue, that affect the determination of the amount and timing of our revenue from contracts with customers. Based on the current facts and circumstances related to our contracts with customers, none of the judgments we make involve an elevated degree of qualitative significance or complexity such that further disclosure is warranted in terms of their potential impact on the amount and timing of our revenue.


Contract Assets and Contract Liabilities

We do not currently generate material contract assets. During the three months ended March 31, 2022, our contract liability changed only as a result of routine business activity.

During the three months ended March 31, 2022 and 2021, the amount of revenue we recognized that was included in the beginning balance of Contract liability was not material.

During the three months ended March 31, 2022 and 2021, we did not recognize revenue from performance obligations that were satisfied in previous periods.


NOTE 4. TRADE ACCOUNTS RECEIVABLE
March 31, 2022December 31, 2021
Gross accounts receivable balance$12,563 $11,551 
Allowance for bad debt(1,270)(1,284)
Accounts receivable, net$11,293 $10,267 


Generally, it is not unusual for Chinese entities to pay their vendors on longer timelines than the timelines typically observed in U.S. commerce. Trade receivables related to the VIEs’ AI projects, including $2.7 million of trade receivables from projects related to work with our China Business Partner (see Note 13 for more information regarding our China Business Partner and related accounting), represent 99% of our gross trade receivables.




NOTE 5. INVESTMENT

In 2009, we co-founded a U.S.-based venture, Sharecare, Inc. (“Legacy Sharecare”), to build a web-based platform that simplifies the search for health and wellness information. The other co-founders of Legacy Sharecare were Dr. Mehmet Oz, HARPO Productions, Discovery Communications, Jeff Arnold and Sony Pictures Television. At December 31, 2021, we reported our $1.0 million investment in Legacy Sharecare as an investment in unconsolidated affiliate.

On July 1, 2021, Legacy Sharecare completed a business combination with Falcon Capital Acquisition Corp., a special purpose acquisition company, as a result of which the common stock of the surviving entity of such business combination (“New Sharecare”) became listed on the Nasdaq Stock Market LLC. In connection with the completion of such business combination, the shares of common stock of Legacy Sharecare that we held immediately prior to the business combination converted into approximately $2.3 million in cash and approximately 9.4 million shares of common stock of New Sharecare. We do not maintain a seat on the board of directors of New Sharecare. The cash received was recorded as a realized gain on the investment, and the investment is revalued at fair value at the end of each reporting period using the closing sales price of the shares on the principal securities exchange on which such shares are then traded.

As of March 31, 2022 and December 31, 2021, the value of our investment in New Sharecare was $21.4 million and $42.3 million, respectively, based upon the closing stock price of New Sharecare, an input we classify in Level 1 of the fair value hierarchy, on such dates. We sold 750,000 shares of New Sharecare during the three months ended March 31, 2022 for cash of $1.8 million. The total loss on investment during the three months ended March 31, 2022 was as follows:

Realized loss$1,518 
Unrealized loss17,538 
Total loss$19,056 


NOTE 6. PREPAID EXPENSE AND OTHER CURRENT ASSETS

The following table presents the components of prepaid expense and other current assets (in thousands):
March 31, 2022December 31, 2021
Receivable from China Business Partner$ $3,980 
Deferred cost of revenue4,764 589 
Other receivables
1,850 9 
Prepaid expense
1,396 1,558 
Deposits
257 221 
Other current assets
6 6 
Total
$8,273 $6,363 




NOTE 7. PROPERTY AND EQUIPMENT
Property and equipment consist of the following (in thousands, except estimated lives):
Estimated Life
(Years)
March 31, 2022December 31, 2021
Computers and equipment31,140 1,133 
Furniture and fixtures342 42 
Software35,068 5,055 
Leasehold improvements3195 196 
Software development in progress1,085 128 
Total property, equipment and software$7,530 $6,554 
Less accumulated depreciation(6,256)(6,197)
Total property, equipment and software, net$1,274 $357 


For the three months ended March 31, 2022 and 2021, there was a de minimis amount of depreciation (and amortization of software) expense and $0.1 million of depreciation (and amortization of software) expense, respectively.



NOTE 8. LEASES

We and the VIEs lease office space under contracts we classify as operating leases. None of our leases are financing leases.

The following table presents the detail of our lease expense, which is reported in General and administrative expense (in thousands):
Three Months Ended March 31,
20222021
Operating lease expense
$72 $355 
Short-term lease expense
437 7 
Lease expense
$509 $362 


We reported within operating cash flows for the three months ended March 31, 2022 and 2021, $0.2 million and $0.1 million, respectively, of cash paid for amounts included in the measurement of operating lease liabilities.

As of March 31, 2022, our operating leases had a weighted-average remaining lease term of approximately 16 months, and we used a weighted-average discount rate of approximately 13% to measure our operating lease liabilities.




Maturity of Lease Liabilities

The following table presents information regarding the maturities of undiscounted remaining operating lease payments, with a reconciliation to the amount of the liabilities representing such payments as presented in our March 31, 2022 Consolidated Balance Sheet (in thousands):
Operating lease liabilities maturing during the next:
One year$228 
Two years59 
Total undiscounted cash flows$287 
Present value of cash flows$264 
Lease liabilities on balance sheet:
Short-term (included in accrued expenses)
$209 
Long-term55 
Total lease liabilities$264 


Significant Judgments

When accounting for our leases, we make certain judgments, such as whether a contract contains a lease or what discount rate to use, that affect the determination of the amount of our lease assets and liabilities. Based on the current facts and circumstances related to our contracts, none of the judgments we make involve an elevated degree of qualitative significance or complexity such that further disclosure is warranted.


NOTE 9. ACCRUED EXPENSE AND OTHER CURRENT LIABILITIES

The following table presents the components of Accrued expense and other current liabilities (in thousands):
March 31, 2022December 31, 2021
Accrued compensation and benefit-related expense$629 $821 
Accrued interest374 385 
Other accrued expense1,336 1,673 
Other payables2,299 2,324 
Operating lease liability - current209 187 
China Cash Bonuses354 439 
Other current liabilities 134 
Total
$5,201 $5,963 




NOTE 10. DEBT

Short-Term Debt

The following table presents our notes payable (in thousands) as of:
March 31, 2022December 31, 2021
Principal balance of Mudrick Loans$26,303 $30,000 
Unamortized discount and debt issuance cost(1,095)(2,189)
Notes payable, net of unamortized discount and debt issuance cost$25,208 $27,811 


On December 3, 2021, we entered into senior secured loan agreements (the “Mudrick Loan Agreements”) with certain of our subsidiaries as guarantors (the “Guarantors”) and certain institutional lenders affiliated with Mudrick Capital Management, LP (collectively “Mudrick”), pursuant to which Mudrick extended credit to us consisting of term loans in the aggregate principal amount of $30.0 million (the “Mudrick Loans”). The Mudrick Loans bear interest at 16.5% per annum, which shall be payable on the last business day of each month commencing on December 31, 2021. All amounts outstanding under the Mudrick Loans, including all accrued and unpaid interest, will be due and payable in full on July 31, 2022. To secure the payment and performance of the obligations under the Mudrick Loan Agreements, we, together with the Guarantors, have granted to TMI Trust Company, as the collateral agent for the benefit of Mudrick, a first priority lien on, and security interest in, all assets of Remark and the Guarantors, subject to certain customary exceptions. The Mudrick Loan Agreements contain representations, warranties, events of default, indemnifications and other provisions customary for financings of this type. The occurrence of any event of default under the Mudrick Loan Agreements may result in the principal amount outstanding and unpaid interest thereon becoming immediately due and payable. In connection with our entry into the Mudrick Loan Agreements, we paid to Mudrick an upfront fee equal to 5.0% of the amount of the Mudrick Loans, which was netted against the drawdown of the Mudrick Loans and recorded as a discount of $1.5 million, and recorded debt issuance cost totaling $1.1 million. We are amortizing the discount on the Mudrick Loans and the debt issuance cost over the life of the Mudrick Loans and, during the three months ended March 31, 2022, we amortized $1.1 million of such discount and debt issuance cost. See Note 15 for information on a subsequent principal payment on the Mudrick Loans.


NOTE 11. COMMITMENTS AND CONTINGENCIES

At March 31, 2022, we had no material commitments outside the normal course of business.


Contingencies

As of March 31, 2022, we were neither a defendant in any material pending legal proceeding nor are we aware of any material threatened claims against us and, therefore, we have not accrued any contingent liabilities.


Registration Rights Agreement

On September 27, 2021, we entered into a securities purchase agreement (the “Armistice Purchase Agreement”) with Armistice Capital Master Fund Ltd. (“Armistice Capital”) pursuant to which we issued shares of our common stock together with warrants to purchase our common stock, subject to certain customary anti-dilution adjustments (the “Armistice Warrants”).

In connection with our entry into the Armistice Purchase Agreement, we also entered into a registration rights agreement with Armistice Capital, pursuant to which we are obligated to file one or more registration statements, as necessary, to register under the Securities Act of 1933, as amended, the resale of the shares we issued to Armistice Capital and the shares underlying the Armistice Warrants (collectively, the “Armistice Registrable Securities”) and to obtain effectiveness of such registration statement no later than 90 days following September 27, 2021. While we have filed a registration statement to register the resale of the Armistice Registrable Securities (the “Armistice Resale Registration Statement”), we are currently in a comment letter process with the SEC staff with respect to such registration statement and have not been able to achieve effectiveness of the


Armistice Resale Registration Statement. As a result, we accrued $0.6 million at December 31, 2021, representing our best estimate of the liquidated damages we will be required to pay until the SEC declares the Armistice Resale Registration Statement effective or until our registration obligations in the Armistice Registration Rights Agreement terminate. The Armistice Registration Rights Agreement caps such liquidated damages at $1.0 million.


NOTE 12. STOCKHOLDERS' EQUITY, SHARE-BASED COMPENSATION AND NET LOSS PER SHARE

Warrants

The following table summarizes information related to our equity-classified stock warrant issuances as of and for the dates and periods noted:
SharesWeighted Average Exercise Price Per ShareWeighted-Average Remaining Contractual TermAggregate Intrinsic Value (in thousands)
Outstanding at December 31, 202110,114,408 $4.01 4.7$ 
Granted  
Exercised  
Forfeited, cancelled or expired  
Outstanding at March 31, 202210,114,408 $4.01 4.4$ 


Share-Based Compensation 

We are authorized to issue equity-based awards under our 2014 Incentive Plan and our 2017 Incentive Plan, each of which our stockholders have approved. We also award cash bonuses (“China Cash Bonuses”) to our employees in China, which grants are not subject to a formal incentive plan and which can only be settled in cash. We grant such awards to attract, retain and motivate eligible officers, directors, employees and consultants. Under each of the plans, we have granted shares of restricted stock and options to purchase common stock to our officers and employees with exercise prices equal to or greater than the fair value of the underlying shares on the grant date.

Stock options and China Cash Bonuses generally expire 10 years from the grant date. All forms of equity awards and China Cash Bonuses vest upon the passage of time, the attainment of performance criteria, or both. When participants exercise stock options, we issue any shares of our common stock resulting from such exercise from new authorized and unallocated shares available at the time of exercise.


The following table summarizes activity under our equity incentive plans related to equity-classified stock option grants as of and for the dates and periods noted:
SharesWeighted Average Exercise Price Per ShareWeighted-Average Remaining Contractual TermAggregate Intrinsic Value (in thousands)
Outstanding at December 31, 202114,839,020 $3.30 6.1$159 
Granted80,614 0.77 
Exercised  
Forfeited, cancelled or expired(27,500)1.40 
Outstanding at March 31, 202214,892,134 $3.29 5.8$81 
Exercisable at December 31, 202112,776,520 3.62 5.7$957 
Exercisable at March 31, 202213,261,634 3.53 5.5$81 


The following table summarizes activity related to our liability-classified China Cash Bonuses as of and for the dates and periods noted:
SharesWeighted Average Exercise Price Per ShareWeighted-Average Remaining Contractual TermAggregate Intrinsic Value (in thousands)
Outstanding at December 31, 20211,036,000 $3.97 5.4$159 
Forfeited, cancelled or expired  
Outstanding at March 31, 20221,036,000 $3.97 5.0$ 
Exercisable at December 31, 2021886,000 4.41 4.9$ 
Exercisable at March 31, 2022916,000 4.31 4.5$ 


The following table presents the change in the liability associated with our China Cash Bonuses included in Accrued expense and other current liabilities (in thousands):
Three Months Ended March 31,Year Ended December 31,
20222021
Balance at beginning of period
$439 $679 
Share-based compensation expense related to China Cash Bonuses
(85)(240)
Balance at end of period
$354 $439 


On July 27, 2020, the compensation committee of our board of directors approved grants to employees, directors and other service providers, excluding our CEO, of options to purchase approximately 5.4 million shares of our common stock. The option agreements governing the grants contain a stipulation that, regardless of vesting, such options do not become exercisable unless and until stockholders approve an amendment to our Amended and Restated Certificate of Incorporation to increase in the number of authorized shares of our common stock in an amount sufficient to allow for the exercise of the options and we have filed a corresponding Certificate of Amendment to our Amended and Restated Certificate of Incorporation reflecting such increase in the number of authorized shares of our common stock.



On July 8, 2021, our stockholders approved an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of our common stock to 175,000,000, and we filed a Certificate of Amendment to our Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on July 9, 2021 to reflect this amendment, which became effective immediately upon filing.

As a result of the increase in the number of authorized shares of our common stock, we determined that July 8, 2021 was the grant date for accounting purposes of the stock options we originally issued on July 27, 2020. The grant date fair value of the options granted on July 27, 2020 was approximately $6.3 million. To estimate the fair value of the options with an accounting grant date of July 8, 2021, we used the Black-Scholes-Merton option pricing model with an expected volatility of 85%, a risk-free interest rate of 0.34%, and expected term of six years and no expected dividends.

The following table presents a breakdown of share-based compensation cost included in operating expense (in thousands):
Three Months Ended March 31,
20222021
Stock options$514 $19 
China Cash Bonuses(85)248 
Total$429 $267 


We record share-based compensation expense in the books of the subsidiary that incurs the expense, while for equity-classified stock options we record the change in additional paid-in capital on the corporate entity because the corporate entity’s equity underlies such stock options.

The following table presents information regarding unrecognized share-based compensation cost associated with stock options and China Cash Bonuses:
March 31, 2022
Unrecognized share-based compensation cost for non-vested awards (in thousands):
Stock options1,564 
China Cash Bonuses63 
Weighted-average years over which unrecognized share-based compensation expense will be recognized:
Stock options0.8
China Cash Bonuses0.8


NOTE 13. CHINA BUSINESS PARTNER

We and the VIEs interact with an unrelated entity (the “China Business Partner”) in more than one capacity. Firstly, since 2020, one of the VIEs has been working with the China Business Partner to earn revenue by obtaining business from some of the largest companies in China. Secondly, our artificial intelligence business in the U.S. has, to date, purchased substantially all of its inventory from a subsidiary of the China Business Partner which manufactures certain equipment to our specifications; though, during the quarter ended March 31, 2022, we did not make a material amount of such purchases. In addition, a member of our senior leadership team maintains a role in the senior management structure of the China Business Partner.

During the prior years, one of the VIEs advanced an aggregate of approximately $4.0 million to the China Business Partner pursuant to an agreement between the two entities. Under the executed agreement, the VIE had an obligation to advance as much as an aggregate amount of $5.1 million over the loan term of five years, and the VIE could elect to convert amounts due to it under the agreement into equity of the China Business Partner upon any equity financing the China Business Partner undertook during the term of the agreement. The business purpose for the advances was to allow the China Business Partner to purchase and modify hardware to integrate with our software and market such integrated product to potential customers, including some of the largest companies in China. During the period ended March 31, 2022, the China Business Partner repaid the advances in full.



During the three months ended March 31, 2022, the VIEs recognized approximately $2.2 million of revenue from the relationship with the China Business Partner, which amount was recorded in accounts receivable.




NOTE 14. CONSOLIDATING FINANCIAL SCHEDULES

Please see Note 1 for information regarding our corporate structure and our relationship to the VIEs.


Consolidating Balance Sheets (Unaudited)
March 31, 2022
($ in thousands)
Corporate & Non-VIE EntitiesVIEsEliminating EntriesConsolidated Total
Assets
Cash$2,604 $87 $ $2,691 
Trade accounts receivable, net4 11,289  11,293 
Inventory, net1,433 59  1,492 
Investment in marketable securities21,444   21,444 
Prepaid expense and other current assets3,520 4,753  8,273 
Total current assets29,005 16,188  45,193 
Property and equipment, net1,272 2  1,274 
Operating lease assets92 154  246 
Investment in VIEs9,011  (9,011) 
Other long-term assets375 28  403 
Total assets$39,755 $16,372 $(9,011)$47,116 
Liabilities
Accounts payable$4,244 $5,855 $ $10,099 
Accrued expense and other current liabilities2,612 2,589  5,201 
Contract liability306 126  432 
Notes payable, net of unamortized discount and debt issuance cost25,208   25,208 
Total current liabilities32,370 8,570  40,940 
Operating lease liabilities, long-term 55  55 
Total liabilities32,370 8,625  40,995 
Stockholders’ Equity
Preferred stock    
Common stock105 163 (163)105 
Additional paid-in-capital364,753 30,368 (30,368)364,753 
Accumulated other comprehensive income996 (1,289)25 (268)
Accumulated deficit(358,469)(21,495)21,495 (358,469)
Total stockholders’ equity7,385 7,747 (9,011)6,121 
Total liabilities and stockholders’ equity$39,755 $16,372 $(9,011)$47,116 



<
Consolidating Statement of Operations (Unaudited)
Three Months Ended March 31, 2022
($ in thousands)
Corporate & Non-VIE EntitiesVIEsEliminating EntriesConsolidated Total
Revenue$181 $4,653 $(167)$4,667 
Cost and expense
Cost of revenue (excluding depreciation and amortization)44 4,226  4,270 
Sales and marketing53 95  148 
Technology and development(19)474  455 
General and administrative4,012 94 (167)3,939 
Depreciation and amortization41   41 
Total cost and expense4,131 4,889 (167)8,853 
Operating loss(3,950)(236) (4,186)
Other income (expense)
Interest expense(2,186)  (2,186)
Loss on investment(19,056)